Trial · NCT00619801
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Ventricular Rate (VR) | Baseline, 14 days | |
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in RR Interval | Baseline, 14 days | The RR interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in PR Interval | Baseline, 14 days | The PR interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in QRS Duration | Baseline, 14 days | The QRS duration refers to the respective time duration in the Electrocardiogram (ECG). |
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in QT Interval | Baseline, 14 days | The QT interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Primary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in QT Interval Corrected for Heart Rate Using Fridericia's Formula (QTcF) | Baseline, 14 days | The QT interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Primary | Absolute Value of QT Interval Corrected for Heart Rate Using Fridericia's Formula (QTcF) at Visit 3 (Day 7) | 7 days | The QT interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Primary | Absolute Value of QT Interval Corrected for Heart Rate Using Fridericia's Formula (QTcF) at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) | 14 days | The QT interval refers to the respective time interval in the Electrocardiogram (ECG). |
| Secondary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Total Bilirubin | Baseline, 14 days | |
| Secondary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Alanine Aminotransferase (ALT) | Baseline, 14 days | |
| Secondary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Aspartate Aminotransferase (AST) | Baseline, 14 days | |
| Secondary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Blood Urea Nitrogen | Baseline, 14 days | |
| Secondary | Change From Baseline at Visit 4 (Day 14) or at Early Discontinuation Visit (EDV) in Blood Creatinine | Baseline, 14 days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00619801/registered